The effect of partial compliance on the prevention of recurrent preterm birth in women receiving weekly 17 alpha-hydroxyprogesterone caproate injections

被引：2
|
作者：
Haidar, Ziad A. [1 ]
Moussa, Hind N. [1 ]
Sibai, Baha M. [1 ]
机构：
[1] UT Hlth Univ Texas Med Sch Houston, Houston, TX USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2016年 / 214卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2015.10.577
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
533
引用
收藏
页码：S288 / S288
页数：1
相关论文
共 50 条
  • [31] 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length
    Berghella, Vincenzo
    Figueroa, Dana
    Szychowski, Jeff M.
    Owen, John
    Hankins, Gary D. V.
    Iams, Jay D.
    Sheffield, Jeanne S.
    Perez-Delboy, Annette
    Wing, Deborah A.
    Guzman, Edwin R.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (04) : 351.e1 - 351.e6
  • [32] 17 α-Hydroxyprogesterone Caproate (Makena™)In the Prevention of Preterm Birth
    Emma D. Deeks
    Pediatric Drugs, 2011, 13 : 337 - 345
  • [33] 17 α-Hydroxyprogesterone Caproate (Makena™) In the Prevention of Preterm Birth
    Deeks, Emma D.
    PEDIATRIC DRUGS, 2011, 13 (05) : 337 - 345
  • [34] 17-Alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length
    Berghella, Vincenzo
    Figueroa, Dana
    Szychowski, Jeff
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S7 - S7
  • [35] Conformity with treatment standards and pregnancy outcomes in patients receiving 17 alpha-hydroxyprogesterone caproate (17p) for preterm birth prophylaxis
    Istwan, Niki
    Rhea, Debbie
    Desch, Cheryl
    Stanziano, Gary
    Gonzalez-Quintero, Victor Hugo
    Tudela, Felipe Jose
    Romary, Leticia Maria
    Cordova, Yvette C.
    Achille, Fabienne
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S81 - S81
  • [36] Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention
    Zhang, Shiyu
    Rascati, Karen L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1667 - 1675
  • [37] Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate
    Szychowski, Jeff M.
    Berghella, Vincenzo
    Owen, John
    Hankins, Gary
    Iams, Jay D.
    Sheffield, Jeanne S.
    Perez-Delboy, Annette
    Wing, Deborah A.
    Guzman, Edwin R.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (12): : 2686 - 2689
  • [38] Characteristics of women not receiving treatment with 17-alpha-hydroxyprogesterone-caproate for a history of spontaneous preterm birth
    Massa, Katherine
    Lawlor, Megan L.
    Boerrigter, Ashley
    Vricella, Laura K.
    Childress, Katherine S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S574 - S575
  • [39] Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
    How, Helen Y.
    Barton, John R.
    Istwan, Niki B.
    Rhea, Debbie J.
    Stanziano, Gary J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (03) : 260.e1 - 260.e4
  • [40] Effect of 17-alpha-hydroxyprogesterone caproate injections on rate of cervical length change in women with a history of prior preterm birth
    Ibrahim, Sherrine
    Lynch, Courtney
    Walker, Hetty
    Rodewald, Katherine
    Iams, Jay
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S225 - S225
12345